Siemens Healthineers to expand product line in China
Siemens Healthineers is to launch about 20 “made-in-China” products in the 2025 fiscal year, according to a report in China Daily.
Related Articles
SS Innovations International makes historic NASDAQ debut
SS Innovations International makes historic NASDAQ debut
Nitish Kumar Launches 1050-Bed PMCH Healthcare Milestone
Bihar Chief Minister Nitish Kumar has unveiled a groundbreaking healthcare milestone with the inauguration of a massive 1050-bed facility at Patna Medical …
Manipal, Max Healthcare, and KKR Line Up to Bid for Sahyadri Hospitals
The hospital chain, owned by Canada’s Ontario Teachers’ Pension Plan Board (OTPP), has extended its initial May 1 bid deadline by several weeks. Warburg Pincus…
Intuitive and HSSC come together to strengthen India’s healthcare workforce
Intuitive and HSSC come together to strengthen India’s healthcare workforce
Marked improvement in accessibility of healthcare services due to Ayushman Arogya Mandirs: Minister – ET HealthWorld
Ayush Healthcare Services: “The initiative of establishment of 12,500 Ayushman Arogya Mandirs has significantly enhanced healthcare availability, with the number of beneficiaries rising from 1.5…
Thoughtful.ai Announces Growth Investment from New Mountain Capital
Thoughtful Automation Inc. (“Thoughtful.ai”), a leading artificial intelligence (AI)-powered revenue cycle automation company, today announced a strategic in…
How health systems are tackling the rise of ‘shadow AI’ – Becker’s Hospital Review | Healthcare News & Analysis
Shadow AI—the use of unauthorized or unmonitored AI tools within organizations—is an escalating concern, particularly in sectors like healthcare where data privacy and compliance are…
KLAS: Global Healthcare IT Investments and Trends for 2025
A recent report by KLAS Research highlights the key trends shaping healthcare IT investments across the globe in 2025.
RadNet completes €91M deal to purchase iCAD
RadNet aims to broaden its breast imaging AI offerings with the acquisition of iCAD.
Precision Neuroscience wins FDA clearance for BCI cortical interface
Precision Neuroscience announced today that it received FDA 510(k) clearance for its Layer 7 cortical interface for BCI technology.